ATE192656T1 - Verfahren zur behandlung von patienten mit chronischer lebererkrankung - Google Patents

Verfahren zur behandlung von patienten mit chronischer lebererkrankung

Info

Publication number
ATE192656T1
ATE192656T1 AT92919793T AT92919793T ATE192656T1 AT E192656 T1 ATE192656 T1 AT E192656T1 AT 92919793 T AT92919793 T AT 92919793T AT 92919793 T AT92919793 T AT 92919793T AT E192656 T1 ATE192656 T1 AT E192656T1
Authority
AT
Austria
Prior art keywords
pct
liver disease
chronic liver
treating patients
patients
Prior art date
Application number
AT92919793T
Other languages
English (en)
Inventor
Niels Erik Skakkebaek
Soeren Moeller
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE192656T1 publication Critical patent/ATE192656T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
AT92919793T 1991-09-05 1992-08-18 Verfahren zur behandlung von patienten mit chronischer lebererkrankung ATE192656T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK911554A DK155491D0 (da) 1991-09-05 1991-09-05 Behandling af patienter med kronisk leversygdom
PCT/DK1992/000245 WO1993004694A1 (en) 1991-09-05 1992-08-18 A method for treatment of patients with chronic liver disease

Publications (1)

Publication Number Publication Date
ATE192656T1 true ATE192656T1 (de) 2000-05-15

Family

ID=8106016

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92919793T ATE192656T1 (de) 1991-09-05 1992-08-18 Verfahren zur behandlung von patienten mit chronischer lebererkrankung

Country Status (11)

Country Link
US (1) US5492891A (de)
EP (1) EP0602172B1 (de)
JP (1) JP3105541B2 (de)
AT (1) ATE192656T1 (de)
AU (1) AU664201B2 (de)
CA (1) CA2116535C (de)
DE (1) DE69231036T2 (de)
DK (2) DK155491D0 (de)
ES (1) ES2148180T3 (de)
GR (1) GR3034096T3 (de)
WO (1) WO1993004694A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1942995A (en) * 1994-03-15 1995-10-03 K.U. Leuven Research & Development New use of growth hormone
NL9401045A (nl) * 1994-03-15 1995-10-02 Leuven K U Res & Dev Nieuw gebruik van groeihormoon.
US5705482A (en) * 1995-01-13 1998-01-06 Novo Nordisk A/S Pharmaceutical formulation
JP3869874B2 (ja) * 1995-11-15 2007-01-17 大日本住友製薬株式会社 急性肝不全治療剤
ES2146530B1 (es) * 1997-12-26 2001-04-16 Consejo Superior Investigacion Utilizacion del factor de crecimiento igf-i en la fabricacion de composiciones utiles en el tratamiento de la ataxia cerebelar.
RU2203675C1 (ru) * 2001-12-29 2003-05-10 Челябинский государственный институт лазерной хирургии Способ патогенетической терапии хронических заболеваний печени
RU2204399C1 (ru) * 2001-12-29 2003-05-20 Челябинский государственный институт лазерной хирургии Способ патогенетического лечения хронических заболеваний печени в эксперименте
DK1517988T3 (da) * 2002-06-20 2013-07-22 Augustinus Bader Anvendelse af erythropoietin til vævsregenerering in vivo
DE60330269D1 (de) 2002-10-23 2010-01-07 Janssen Pharmaceutica Nv Piperazinyl- und diazapanylbenzamide und-benzothioamide
ES2383685T3 (es) * 2003-04-30 2012-06-25 Kenji Kangawa Preventivos o remedios para hepatopatía
EP1574211A1 (de) * 2004-03-09 2005-09-14 Inserm Verwendung von CB1-Rezeptor-Antagonisten zur Herstellung eines Arzneimittels zur Behandlung von Lebererkrankungen
RU2333020C1 (ru) * 2007-04-05 2008-09-10 Государственное образовательное учреждение дополнительного профессионального образования "Новокузнецкий государственный институт усовершенствования врачей Федерального агентства по здравоохранению и социальному развитию" Способ реабилитации больных с постхолецистэктомическим синдромом

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898857A (en) * 1984-10-29 1990-02-06 Chaovanee Aroonsakul Treating control nervous system diseases
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
WO1991011195A1 (en) * 1990-02-02 1991-08-08 Novo Nordisk A/S A method of treating a mammal with a biologically active compound

Also Published As

Publication number Publication date
EP0602172A1 (de) 1994-06-22
ES2148180T3 (es) 2000-10-16
JPH06510292A (ja) 1994-11-17
CA2116535A1 (en) 1993-03-18
GR3034096T3 (en) 2000-11-30
WO1993004694A1 (en) 1993-03-18
AU664201B2 (en) 1995-11-09
JP3105541B2 (ja) 2000-11-06
CA2116535C (en) 2000-10-31
US5492891A (en) 1996-02-20
AU2579892A (en) 1993-04-05
EP0602172B1 (de) 2000-05-10
DK155491D0 (da) 1991-09-05
DE69231036D1 (de) 2000-06-15
DE69231036T2 (de) 2000-11-02
DK0602172T3 (da) 2000-10-02

Similar Documents

Publication Publication Date Title
DE69231036D1 (de) Verfahren zur behandlung von patienten mit chronischer lebererkrankung
DE69230112D1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
DE69616376D1 (de) Verwendung von Tiagabin zur Behandlung von Schlafstörungen
DK0754048T3 (da) Behandling af partielt væksthormon-insentivitetssyndrom
SE8703625D0 (sv) New medical use
ZA923980B (en) Hepatocyte Growth stimulation
DK0597033T3 (da) IGF-1 til forbedring af den neurale tilstand
ATE93138T1 (de) Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
DK0573604T3 (da) Fremgangsmåde til behandling af osteoporosis
ATE342067T1 (de) Verfahren zur behandlung von vaskulären proliferativen erkrankungen mit p27 und fusionen davon
ATE30326T1 (de) Cyclische pentapeptide mit somatostatin antagonistischer wirksamkeit und verfahren zur behandlung von saeugetieren damit.
DE69226835D1 (de) Verfahren und zusammensetzungen zur behandlung von diabetes mellitus, hypoglykämie und anderer krankhafter zustände
DE69636654D1 (de) Verfahren zur verabreichung von igf-1
SE9300105D0 (sv) Stable protein solution
ATE201598T1 (de) Verwendung von moxonidin zur behandlung neuropathischer schmerzen
ATE190499T1 (de) Methode zur behandlung von reproduktionserkrankungen
ATE165008T1 (de) Methode zur behandlung intestinaler krankheiten
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
DE69428995D1 (de) Verfahren zur behandlung von neoplastischen erkrankungen unter verwendung von tiazofurin und ribavirin
ATE291918T1 (de) Kombinationstherapie zur behandlung von tumoren
DE69319341D1 (de) Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion
ATE246511T1 (de) Behandlung des partiellen wachstumshormon- unempfindlichkeitssyndroms
DE69433687D1 (de) Die verwendung von wachstumshormon zur herstellung eines medikaments zur behandlung der ischämischen hirnschädigung und demenz
ATE147988T1 (de) Authentischen igf-1 und hypokalorische menge von nährstoffen enthaltendes produkt und dessen verwendung zur behandlung kataboler zustände
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee